本文已被：浏览 482次 下载 233次
投稿时间：2022-02-08 网络发布日期：2022-07-20
投稿时间：2022-02-08 网络发布日期：2022-07-20
中文摘要: 目的 评价并总结糖尿病前期人群管理的循证医学证据，并总结最佳证据。方法 计算机检索Up-To-Date、Cochrane Library、Medline、PubMed、中国生物医药文献数据库、万方、中国知网、医脉通等数据库最近十年中关于糖尿病前期管理的所有证据，包括指南、专家共识、证据总结、系统评价等。采用JBI证据预分级及证据推荐级别系统(2014)对证据进行级别和推荐强度的划分。结果 共纳入文献8篇，其中指南3篇，专家共识3篇，系统评价2篇。最终得出包括评估、健康教育、生活方式干预、监测、药物干预、中医干预和心理干预7个方面汇总15条最佳证据。结论 糖尿病前期管理中，应结合临床情境及应用证据的促进及阻碍因素选择最佳证据，以形成更科学的、有循证依据的管理方案。
Abstract:Objective To evaluate and summarize the best evidence for the management of prediabetes.
Methods All evidences on prediabetes management in Up-To-Date, Cochrane Library, Medline, PubMed, China Biomedical Literature Database, Wanfang, CNKI, Yimaitong and other databases in recent 10 years were searched by computer, including guidelines, expert consensus, evidence summary and systematic evaluation, etc. By JBI Evidence Pre-Grading and Evidence Recommendation Grading System (2014), the level of evidence and the strength of recommendation were classified.
Results A total of 8 literatures were included, including 3 guidelines, 3 expert consensuses and 2 systematic reviews. Finally, 15 pieces of best evidence were summarized, covering 7 aspects of evaluation, health education, lifestyle intervention, monitoring, drug intervention, traditional Chinese medicine intervention and psychological intervention.
Conclusion In the management of prediabetes, the best evidence should be selected in combination with the clinical situation and the promoting and hindering factors of the applied evidence, so as to form a more scientific and evidence-based management plan.
文章编号： 中图分类号：R587.1 文献标志码：A
基金项目:国家重点研发计划项目（2018YFC2002102）；山东省软科学一般项目（2020RKB01782）；青岛市民生科技计划项目
引用文本：
李丽,毛拥军,胡松,等.糖尿病前期人群管理的循证医学证据总结[J].中国临床研究,2022,35(7):943-947.
李丽,毛拥军,胡松,等.糖尿病前期人群管理的循证医学证据总结[J].中国临床研究,2022,35(7):943-947.